Preclinical and clinical properties of elbasvir (ERELSA® Tablets 50 mg) and Grazoprevir (GRAZYNA® Tablets 50 mg), novel therapeutic agents for hepatitis C
Kinoshita, Kiyoshi, Iwasa, Takashi, Asante-Appiah, Ernest, Nakamura, KeisukeVolume:
150
Year:
2017
Journal:
Folia Pharmacologica Japonica
DOI:
10.1254/fpj.150.41
File:
PDF, 1.21 MB
2017